||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 564 active entries
500 Kendall Street
Cambridge, MA 02142
United States of America, Massachusetts
Phone: (617) 252-7500
Fax: (617) 252-7600
Stock symbol: GENZ
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
One of the world’s foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues approaching $2 billion and more than 5,600 employees in locations spanning the globe. Its headquarters is located in Cambridge, Massachusetts.
With many established products and services helping patients in over 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences to address a range of unmet medical needs. The company's products and services are focused on rare inherited disorders, kidney disease, osteoarthritis, immune-system disorders, and diagnostic testing. Genzyme's commitment to innovation continues today with research into novel approaches to cancer, heart disease, and other areas of medicine.
Last update of this entry: April 06, 2004